ClinicalTrials.gg
WithdrawnNCT03875833Updated May 22, 2023

Prospective Analysis of Effect of Collagen Wrap Conduit on Radial and Ulnar Nerve Function Following Radial/Ulnar Forearm Free Flap Harvest

An interventional study of Collagen Nerve Wrap Conduit in Head and Neck Neoplasms and Dysesthesia, sponsored by The University of Texas Health Science Center, Houston. Withdrawn. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-05-22.

Sponsored by The University of Texas Health Science Center, Houston · Not applicable, Interventional, and Treatment

Why this study was withdrawn
Lack of enrollment
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to determine whether collagen nerve conduits placed on exposed radial and ulnar nerves during radial and ulnar forearm free flap harvests will reduce the occurrence and degree of sensory nerve deficit.

02

Conditions studied

  • Head and Neck Neoplasms
  • Dysesthesia
03

In context

Head and Neck Neoplasms

2,710 studies on the registry are indexed under Head and Neck Neoplasms; 594 are open to participants now.

Browse Head and Neck Neoplasms studies →

Lead sponsor

The University of Texas Health Science Center, Houston is the lead sponsor of 897 studies on the registry; 214 are open to participants now.

Of its 173 completed or terminated interventional studies of FDA-regulated products, 142 (82%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • patients present with a complex defect after tumor resection
  • all these cases done with the departments of Oral and Maxillofacial Surgery and Otolaryngology at the University of Texas in multiple locations that include, Memorial Hermann Hospital, Ben Taub General Hospital, Lyndon B. Johnson General Hospital and The Methodist hospital.
  • patients that have been diagnosed with head and neck tumors and who will undergo a composite resection and reconstruction with radial or ulnar free vascularized flap.

Exclusion criteria

Exclusion Criteria:

  • pre-existing nerve deficits
  • pregnant women
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    Collagen Nerve Wrap Conduit

    Device: Collagen Nerve Wrap Conduit

  • No intervention
    Control

Interventions

  • DeviceCollagen Nerve Wrap Conduit

    The collagen nerve wrap conduit will be placed on all exposed radial and ulnar nerves at the time of free flap harvest.

06

What researchers measure

Primary outcomes

  1. Number of participants with normal sensory recovery at the site of forearm free flap as assessed by subjective patient questionnaire regarding upper extremity sensation and function

    Time frame: baseline

  2. Number of participants with normal sensory recovery at the site of forearm free flap as assessed by subjective patient questionnaire regarding upper extremity sensation and function

    Time frame: 3 months

  3. Number of participants with normal sensory recovery at the site of forearm free flap as assessed by subjective patient questionnaire regarding upper extremity sensation and function

    Time frame: 6 months

  4. Number of participants with normal sensory recovery at the site of forearm free flap as assessed by subjective patient questionnaire regarding upper extremity sensation and function

    Time frame: 12 months

  5. Number of participants with normal sensory recovery at the site of forearm free flap as assessed by objective clinical findings

    Participants will be evaluated clinically using pinprick, light touch, and two-point discrimination tests. An overall score will be reported.

    Time frame: baseline

  6. Number of participants with normal sensory recovery at the site of forearm free flap as assessed by objective clinical findings

    Participants will be evaluated clinically using pinprick, light touch, and two-point discrimination tests. An overall score will be reported.

    Time frame: 3 months

  7. Number of participants with normal sensory recovery at the site of forearm free flap as assessed by objective clinical findings

    Participants will be evaluated clinically using pinprick, light touch, and two-point discrimination tests. An overall score will be reported.

    Time frame: 6 months

  8. Number of participants with normal sensory recovery at the site of forearm free flap as assessed by objective clinical findings

    Participants will be evaluated clinically using pinprick, light touch, and two-point discrimination tests. An overall score will be reported.

    Time frame: 12 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 22, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03875833
Responsible party
James C Melville (Assistant Professor, The University of Texas Health Science Center, Houston) — Principal investigator
First posted
Mar 15, 2019
Start date
Oct 9, 2020
Primary completion
Jan 1, 2024 (estimated)
Completion
Jan 1, 2024 (estimated)
Last update
May 22, 2023

Study contacts

James C Melville, DDS
principal investigator · The University of Texas Health Science Center, Houston

Oversight

FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in May 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion